Inflammation plays a critical role in tumor cause, progression, and, therefore, patient’s survival. The role of different inflammatory cytokines, chemokines, and growth factors as predictive markers in patients with many kinds of cancer is under discussion. Furthermore, recently, some microRNAs are thought to be related to promoting role in cancer. These predictive biomarkers may be expected as the useful tool of early diagnosis, treatment decision, and estimating prognosis.

We invite authors to contribute original research and review articles that will help to understand the value of inflammation related biomarkers in cancer. We encourage submission of manuscripts on both basic studies and clinical studies.

Potential topics include, but are not limited to:

• The potential of microRNA related to inflammation for early diagnosis of cancer
• The potential of inflammatory biomarkers as tumor marker
• The role of interleikin-17 as a biomarker for cancer progression
• The value of serum C-reactive protein as biomarker in cancer
• Predictive inflammatory biomarkers and their functions in cancer cachexia